Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2003
01/02/2003EP1268546A2 G protein-coupled receptors
01/02/2003EP1268545A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system
01/02/2003EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
01/02/2003EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
01/02/2003EP1268542A2 Therapeutic anti-melanoma compounds
01/02/2003EP1268541A1 7 human ovarian and ovarian cancer associated proteins
01/02/2003EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same
01/02/2003EP1268539A2 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use
01/02/2003EP1268538A2 Human secreted proteins and polynucleotides encoding the same
01/02/2003EP1268537A1 Crystal structure of the (aml1 runt domain)/(cbfbeta) heterodimer and the ternary complex with dna
01/02/2003EP1268536A1 Tcf responsive element
01/02/2003EP1268535A2 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
01/02/2003EP1268534A2 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
01/02/2003EP1268533A2 Novel invertase inhibitors and methods of use
01/02/2003EP1268531A2 Method for the production of bacterial toxins
01/02/2003EP1268530A1 Hepatitis b core antigen fusion proteins
01/02/2003EP1268528A2 Human genes and expression products
01/02/2003EP1268527A2 Nucleic acids, proteins, and antibodies
01/02/2003EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
01/02/2003EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them
01/02/2003EP1268521A1 Receptor-binding compounds and methods for identifying them
01/02/2003EP1268520A2 Receptor-binding compounds and methods for identifying them
01/02/2003EP1268516A1 Methods for detection and treatment of neural cancers
01/02/2003EP1268512A2 A computer based method for identifying conserved invariant peptide motifs
01/02/2003EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
01/02/2003EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
01/02/2003EP1268508A1 Quality control reagents for nucleic acid microarrays
01/02/2003EP1268507A1 Antisense modulation of e2f transcription factor 1 expression
01/02/2003EP1268505A2 Solid phase synthesis method and reagent
01/02/2003EP1268492A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
01/02/2003EP1267944A1 Systemic gene delivery vehicles for the treatment of tumors
01/02/2003EP1267940A1 Compounds for targeting
01/02/2003EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
01/02/2003EP1267933A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
01/02/2003EP1267923A1 Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical composition administered by mucosal delivery
01/02/2003EP1267914A1 Use of lyosomal acid lipase for treating atherosclerosis and related diseases
01/02/2003EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells
01/02/2003EP1267907A1 Use of mia in immunotherapy
01/02/2003EP1267899A2 Salmonella vaccine materials and methods
01/02/2003EP1267893A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
01/02/2003EP1267860A1 Butylnitrone containing compositions for inhibition of cancer development
01/02/2003EP1267834A1 Cationic liposomes
01/02/2003EP1267800A1 Methods of modulating hair growth
01/02/2003EP1267627A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
01/02/2003EP1267626A1 Recombinant parainfluenza virus expression systems and vaccines
01/02/2003EP1234026A4 Method and apparatus for selectively targeting specific cells within a cell population
01/02/2003EP1210944A4 Blood plasma replacement solution
01/02/2003EP1169477A4 ISOLATION OF cDNA ENCODING FOR SECRETED OR MEMBRANAL PROTEINS
01/02/2003EP1169433A4 Human hac3
01/02/2003EP1115886A4 Secreted renilla luciferase
01/02/2003EP1100949A4 Fusion products containing insoluble proteinaceous tag
01/02/2003EP1090138A4 Nucleotide detection method
01/02/2003EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
01/02/2003EP1071811B8 A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site
01/02/2003EP1007725A4 Padlock probe detection
01/02/2003EP1002137A4 Denaturing multi ion polynucleotide chromatography for detecting mutations
01/02/2003EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response
01/02/2003EP0948526A4 Contryphan peptides
01/02/2003EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy
01/02/2003EP0810282A4 Process for obtaining improved strains of trichoderma spp.
01/02/2003EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature
01/02/2003EP0745131B1 Targeting gene therapy
01/02/2003EP0740504B1 Phytophthora resistance gene of catharanthus and its use
01/02/2003EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA
01/02/2003EP0723592B1 Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms
01/02/2003EP0662138B1 Long wap promoter for mammary expression of human protein c
01/02/2003EP0630408B1 PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R)
01/02/2003EP0628074B1 In vitro activation of cytotoxic t cells
01/01/2003CN1388898A Method for identifying cell-specific proteins
01/01/2003CN1388829A High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor
01/01/2003CN1388797A Method for obtaining a surface activation of a solid support for building biochips microarrays
01/01/2003CN1388250A Process for producing L-glutaminic acid
01/01/2003CN1388248A Adenovirus proliferated specifically inside tumor cell to express interferon in high efficiency and its construction method
01/01/2003CN1388247A Method of strengthening specific destination gene expression of cell
01/01/2003CN1388246A Angrpl gene promotor expressed specifically by plant vascular bundle and its application
01/01/2003CN1388136A Double-specificity antibody resisting human ovary cancer and human CD3
01/01/2003CN1388134A Recombined clathrate protein, its producing process, noble metal-recombined clathrate protein compound, its producing process and recombined DNA
01/01/2003CN1388132A Cell death inducing protein and its coding sequence and use
01/01/2003CN1388131A Serial medicine carriers, tyrosine hydrozylase fusion protein as new carrier and its prepn
01/01/2003CN1388130A Human hematopoietic cell relating gene-1
01/01/2003CN1387764A Insecticide suspension of beet noctuid polyhedron virus
01/01/2003CN1097634C Interleukin-6 active inhibitor
01/01/2003CN1097633C Determinating, purifying and testing for rhabdovirus of ichthyophthirius
01/01/2003CN1097632C A mutant E. coli strain with increased succinic acid production
12/2002
12/31/2002USRE37952 Grb3-3 cDNA and polypeptides
12/31/2002US6501009 Expression of Cry3B insecticidal protein in plants
12/31/2002US6501008 For modifying levels of this enzyme in plants; transgenic plants; use enhancing silage or forage crop digestibility, altering plant cell wall and improving kernel growth rates
12/31/2002US6501007 Inhibiting expression of an rna transcription product of the d1 gene of given sequence using an antisense oligonucleotide; controlling daikoku type dwarfism gene d1 expression
12/31/2002US6501006 Nucleic acids conferring chilling tolerance
12/31/2002US6501005 DNA sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants
12/31/2002US6501004 Transgenic reduction of sinapine in crucifera
12/31/2002US6501003 Mouse transformed with a humanized mutant of green fluorescent protein operably linked to the glial fibrillary acidic protein promoter; use determining the neurotoxicity of a substance
12/31/2002US6500960 Method to produce novel polyketides
12/31/2002US6500945 Nucleotides having chiral phosphorus linkages
12/31/2002US6500943 Promoter
12/31/2002US6500942 Rin2, a novel inhibitor of Ras-mediated signaling
12/31/2002US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner
12/31/2002US6500940 Apoptotic-associated polypeptide lifeguard (lfg); use to treat disorder associated with increased or decreaase fas-mediated cell death
12/31/2002US6500939 Human homologue of the rat protein translocation protein sec61-alpha subunit, which plays a role in protein transport across the endoplasmic reticulum; use as probes for the gene diagnosis, gene sources for gene therapy and drug screening
12/31/2002US6500937 Plasmid or vector; sequence encodes mammastatin; useful in the diagnosis and treatment of breast cancer